In this FAQ video, Claudia Rivera, NP, a rheumatology nurse practitioner from East Lansing, Michigan, discusses when to consider a steroid-sparing agent in the management of polymyalgia rheumatica (PMR) and what treatment options are available. While prednisone remains the cornerstone of PMR therapy, long-term steroid use poses significant risks including osteoporosis, diabetes, adrenal suppression, and infection. Claudia reviews guideline-based tapering strategies and highlights scenarios where steroid-sparing agents are clinically appropriate—such as glucocorticoid dependence, frequent disease relapses, or high risk for steroid toxicity. She explores commonly used agents like methotrexate, leflunomide, and azathioprine, as well as the 2023 FDA-approved biologic sarilumab (Kevzara), an IL-6 receptor antagonist. With a practical approach to dosing, side effect management, and patient selection, this video provides essential guidance for optimizing PMR care. For more educational content, visit RhAPP.org.
#PMR #PolymyalgiaRheumatica #SteroidSparing #Methotrexate #Sarilumab #IL6Inhibitor #Rheumatology #AutoimmuneDisease #Glucocorticoids #SteroidTapering #ChronicInflammation #RhAPP
Las Culturistas with Matt Rogers and Bowen Yang
Ding dong! Join your culture consultants, Matt Rogers and Bowen Yang, on an unforgettable journey into the beating heart of CULTURE. Alongside sizzling special guests, they GET INTO the hottest pop-culture moments of the day and the formative cultural experiences that turned them into Culturistas. Produced by the Big Money Players Network and iHeartRadio.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
24/7 News: The Latest
The latest news in 4 minutes updated every hour, every day.